Alcala Alejandro 4

4 · Crane Co · Filed Aug 27, 2025

Form 4

Period: 2025-08-25

Exec. V.P. & Chief Op. Officer

Transactions

Sale
Common Stock
2025-08-25$192.50/sh−15,358$2,956,415→ 38,959 total
Exercise/Conversion
Common Stock
2025-08-25$51.32/sh+12,134$622,717→ 45,660 total
Exercise/Conversion
Common Stock
2025-08-25$64.86/sh+8,657$561,493→ 54,317 total
Sale
Common Stock
2025-08-25$193.30/sh−4,800$927,840→ 34,159 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2025-08-25−8,657→ 0 total
Exercise: $64.86Exp: 2028-01-29→ Common Stock (8,657 underlying)
Exercise/Conversion
Employee Stock Option (Right to Buy)
2025-08-25−12,134→ 0 total
Exercise: $51.32Exp: 2027-01-30→ Common Stock (12,134 underlying)
Sale
Common Stock
2025-08-25$194.26/sh−633$122,967→ 33,526 total

Holdings

Footnotes (6)

[F1]Mr. Alcala exercised certain options that were nearing expiration.
[F2]Weighted average price at which shares were sold ranged from $191.85 to $192.85. The reporting person undertakes to provide, upon request of the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
[F3]Weighted average price at which shares were sold ranged from $192.86 to $193.86. The reporting person undertakes to provide, upon request of the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
[F4]Weighted average price at which shares were sold ranged from $194.09 to $194.34. The reporting person undertakes to provide, upon request of the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
[F5]The options were granted 1/30/2017 with a ten-year term and vested 25% each year over four years.
[F6]The options were granted 1/29/2018 with a ten-year term and vested 25% each year over four years.

Documents

1 file